Cargando…
Downregulation of S100A9 Reverses Cisplatin-Resistance and Inhibits Proliferation and Migration in Hypopharyngeal Carcinoma
PURPOSE: Patients with hypopharyngeal carcinoma (HPC) often progress to an advanced clinical stage at diagnosis. Cisplatin has been widely used in first-line chemotherapy for advanced HPC. However, acquired chemotherapeutic resistance leads to recurrence, metastasis, and a poor survival rate. Theref...
Autores principales: | Zeng, Shiyu, Tan, Guolin, Wang, Tiansheng, Wang, Xianyao, Zhou, Zheng, Xiao, Jian, Li, Tieqi, Zhang, Gehou, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444389/ https://www.ncbi.nlm.nih.gov/pubmed/36072966 http://dx.doi.org/10.1155/2022/9341731 |
Ejemplares similares
-
LncRNA NR120519 Blocks KRT17 to Promote Cell Proliferation and Migration in Hypopharyngeal Squamous Carcinoma
por: Zhou, Zheng, et al.
Publicado: (2023) -
Analysis of ceRNA network of differentially expressed genes in FaDu cell line and a cisplatin-resistant line derived from it
por: Zhang, Gehou, et al.
Publicado: (2021) -
Identity of
MMP1
and its effects on tumor progression in head and neck squamous cell carcinoma
por: Zhang, Gehou, et al.
Publicado: (2022) -
HOXA11-AS1 Promotes PD-L1-Mediated Immune Escape and Metastasis of Hypopharyngeal Carcinoma by Facilitating PTBP1 and FOSL1 Association
por: Zhou, Zheng, et al.
Publicado: (2022) -
Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
por: Wang, Xiaolin, et al.
Publicado: (2023)